4//SEC Filing
Bahrt Kenneth 4
Accession 0001209191-19-011377
CIK 0001649989other
Filed
Feb 18, 7:00 PM ET
Accepted
Feb 19, 8:23 PM ET
Size
5.8 KB
Accession
0001209191-19-011377
Insider Transaction Report
Form 4
Bahrt Kenneth
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2019-02-19+600,000→ 600,000 totalExercise: $1.32Exp: 2029-02-19→ Common Stock (600,000 underlying)
Footnotes (1)
- [F1]The shares underlying the option shall vest in four equal installments beginning on February 19, 2020 such that the option shall be vested in full on February 19, 2023, subject to the Reporting Person providing continuous service to the Issuer on each such date. Vesting may be accelerated in the event of (a) a change in control as defined in the Issuer's 2015 Equity Incentive Plan and (b) the achievement of certain pre-defined corporate objectives, in each case subject to the Reporting Person providing continuous service to the Issuer through such event.
Documents
Issuer
Outlook Therapeutics, Inc.
CIK 0001649989
Entity typeother
Related Parties
1- filerCIK 0001527197
Filing Metadata
- Form type
- 4
- Filed
- Feb 18, 7:00 PM ET
- Accepted
- Feb 19, 8:23 PM ET
- Size
- 5.8 KB